Warning People About Prescription Drugs
For years, Americans have assumed that the FDA was set up to test drugs. If a treatment was not effective or was too dangerous for patients, it never made it to market. If drugs that were…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 346Myriad Did What??? A Stock Split? (MYGN)
How long has it been since a company announced a stock split? More importantly, when was the last from a fairly large company? I can’t recall that off the top of my head either. …
Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this…
Geron Registers Small Number of Shares (GERN)
Geron Corporation (NASDAQ: GERN) had a filing to sell shares that hit after teh close today. Normally this would be a cause for concern since it had a huge run recently. But this turns…
CV Therapeutics Next In Bio-Health Merger Line (CVTX)
CV Therapeutics, Inc. (NASDAQ: CVTX) is seeing a surge in its shares this morning. It looks like CV is the next biotech merger target now that Astellas Pharma Inc. submitted a $16.00 buyout offer…
IPO Filing: Medidata Solutions, Inc. (MDSO)
Medidata Solutions, Inc. has filed with the SEC to come public via an initial public offering. The company has applied to take the ticker "MDSO" on NASDAQ. Citigroup and Credit Suisse were listed as…
The Recession Damages R&D Spending (AAPL)(PFE)(MSFT)(GOOG)(DNA)
Thomas Alva Edison accumulated 1,093 US patents over his lifetime. Most R&D operations are not that efficient. Corporations hate research. It is expensive. The scientists know more about a company’s products than the management…
Medtronic Adjusts Long-Term Goals (MDT)
Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over and over how this notion has not been the case. Medtronic Inc. (NYSE: MDT)…
100% Buyout Premiums Still Exist (ABT, EYE)
If we told you on Friday that a decent-sized medical merger was coming with a 100% premium, you probably wouldn’t have believed it. We are having a hard time believing it even after the…
La Jolla Gets More Hope (LJPC, BMRN)
La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been more than just a troubled biotech. It has even been considered an at-risk entity by some traders after it had been down more than 90% at…
Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to acquire a large rival…
Auxilium Scores on Pfizer Pact (AUXL, PFE)
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) is responding well in pre-market trading after the company signed an overseas commercialization agreement with Pfizer, Inc. (NYSE: PFE). The pact covers Auxilium’s Xiaflex, a treatment for hand and…
Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)
Biogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies were notified of a confirmed case of progressive multifocal leukoencephalopathy. In other words, it…
Diabetes Trifecta (AMLN, LLY, ALKS)
Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately. But shares have just now gotten back above the single-digit threshold and are up more than 80% from recent lows. This morning Amylin…
Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one of…